Ocugen Capex To Depreciation from 2010 to 2025

OCGN Stock  USD 0.57  0.03  5.56%   
Ocugen Capex To Depreciation yearly trend continues to be very stable with very little volatility. Capex To Depreciation is likely to grow to 2.78 this year. Capex To Depreciation is the ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets. View All Fundamentals
 
Capex To Depreciation  
First Reported
2010-12-31
Previous Quarter
1.72002033
Current Value
2.78
Quarterly Volatility
4.01768105
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Ocugen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ocugen's main balance sheet or income statement drivers, such as Depreciation And Amortization of 582.4 K, Interest Expense of 4.2 M or Selling General Administrative of 15.4 M, as well as many indicators such as Price To Sales Ratio of 51.11, Dividend Yield of 0.0 or PTB Ratio of 7.73. Ocugen financial statements analysis is a perfect complement when working with Ocugen Valuation or Volatility modules.
  
Check out the analysis of Ocugen Correlation against competitors.

Latest Ocugen's Capex To Depreciation Growth Pattern

Below is the plot of the Capex To Depreciation of Ocugen Inc over the last few years. It is the ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets. Ocugen's Capex To Depreciation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ocugen's overall financial position and show how it may be relating to other accounts over time.
Capex To Depreciation10 Years Trend
Slightly volatile
   Capex To Depreciation   
       Timeline  

Ocugen Capex To Depreciation Regression Statistics

Arithmetic Mean3.02
Geometric Mean1.13
Coefficient Of Variation133.03
Mean Deviation2.78
Median1.72
Standard Deviation4.02
Sample Variance16.14
Range14.7569
R-Value0.54
Mean Square Error12.32
R-Squared0.29
Significance0.03
Slope0.45
Total Sum of Squares242.13

Ocugen Capex To Depreciation History

2025 2.78
2024 1.72
2023 14.88
2022 9.29
2021 4.1
2020 3.0
2019 0.49

About Ocugen Financial Statements

Ocugen investors utilize fundamental indicators, such as Capex To Depreciation, to predict how Ocugen Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Capex To Depreciation 1.72  2.78 
When determining whether Ocugen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ocugen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ocugen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ocugen Inc Stock:
Check out the analysis of Ocugen Correlation against competitors.
You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocugen. If investors know Ocugen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocugen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.20)
Revenue Per Share
0.015
Quarterly Revenue Growth
(0.46)
Return On Assets
(0.47)
Return On Equity
(1.54)
The market value of Ocugen Inc is measured differently than its book value, which is the value of Ocugen that is recorded on the company's balance sheet. Investors also form their own opinion of Ocugen's value that differs from its market value or its book value, called intrinsic value, which is Ocugen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocugen's market value can be influenced by many factors that don't directly affect Ocugen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ocugen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocugen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocugen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.